AS-1892802 is primarily utilized in the field of medical research, particularly in the study of neurodegenerative diseases. It functions as a potent and selective inhibitor of Rho-associated protein kinase (ROCK), which plays a significant role in regulating cellular processes such as cell migration, proliferation, and apoptosis. By inhibiting ROCK, AS-1892802 helps researchers investigate its potential therapeutic effects in conditions like Alzheimer's disease, Parkinson's disease, and spinal cord injuries. Additionally, it is used in experimental studies to explore its impact on reducing inflammation and promoting nerve regeneration, making it a valuable tool in developing treatments for neurological disorders. Its application extends to studying cardiovascular diseases, where ROCK inhibition is being explored for its potential to improve vascular function and reduce hypertension.